Results 11 to 20 of about 459,568 (307)

IRB-approved TUTT protocol version 4.0_10 March 2020_.

open access: yes, 2023
IRB-approved TUTT protocol version 4.0_10 March 2020_.
Limakatso Lebina (554886)   +17 more
core   +1 more source

Comparative analyses of vertebrate CPEB proteins define two subfamilies with coordinated yet distinct functions in post-transcriptional gene regulation

open access: yesGenome Biology, 2022
Background Vertebrate CPEB proteins bind mRNAs at cytoplasmic polyadenylation elements (CPEs) in their 3′ UTRs, leading to cytoplasmic changes in their poly(A) tail lengths; this can promote translational repression or activation of the mRNA.
Berta Duran-Arqué   +10 more
doaj   +1 more source

The ATM signaling network in development and disease

open access: yesFrontiers in Genetics, 2013
The DNA damage response (DDR) rapidly recognizes DNA lesions and initiates the appropriate cellular programs to maintain genome integrity. This includes the coordination of cell cycle checkpoints, transcription, translation, DNA repair, metabolism and ...
Travis H. Stracker   +4 more
doaj   +1 more source

Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway

open access: yesNature Communications, 2023
p38α is a versatile protein kinase that can control numerous processes and plays important roles in the cellular responses to stress. Dysregulation of p38α signaling has been linked to several diseases including inflammation, immune disorders and cancer,
Lorena González   +18 more
doaj   +1 more source

Inhibition of p38 MAPK sensitizes tumour cells to cisplatin‐induced apoptosis mediated by reactive oxygen species and JNK

open access: yesEMBO Molecular Medicine, 2013
The p38 MAPK pathway is an important regulator of many cellular responses. It is well established that p38 MAPK signalling negatively regulates epithelial cell transformation, but enhanced p38 MAPK activity has been also correlated with bad clinical ...
Lorena Pereira   +4 more
doaj   +1 more source

Exploring the OncoGenomic Landscape of cancer

open access: yesGenome Medicine, 2018
Background The widespread incorporation of next-generation sequencing into clinical oncology has yielded an unprecedented amount of molecular data from thousands of patients.
Lidia Mateo   +3 more
doaj   +1 more source

Deleterious effects of neuronal accumulation of glycogen in flies and mice

open access: yesEMBO Molecular Medicine, 2012
Under physiological conditions, most neurons keep glycogen synthase (GS) in an inactive form and do not show detectable levels of glycogen. Nevertheless, aberrant glycogen accumulation in neurons is a hallmark of patients suffering from Lafora disease or
Jordi Duran   +5 more
doaj   +1 more source

Encircling the regions of the pharmacogenomic landscape that determine drug response

open access: yesGenome Medicine, 2019
Background The integration of large-scale drug sensitivity screens and genome-wide experiments is changing the field of pharmacogenomics, revealing molecular determinants of drug response without the need for previous knowledge about drug action.
Adrià Fernández-Torras   +2 more
doaj   +1 more source

How Do Cancer-Related Mutations Affect the Oligomerisation State of the p53 Tetramerisation Domain?

open access: yesCurrent Issues in Molecular Biology, 2023
Tumour suppressor p53 plays a key role in the development of cancer and has therefore been widely studied in recent decades. While it is well known that p53 is biologically active as a tetramer, the tetramerisation mechanism is still not completely ...
Federica Nicolini   +7 more
doaj   +1 more source

RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation

open access: yesEMBO Molecular Medicine, 2014
In estrogen receptor‐negative breast cancer patients, metastatic relapse usually occurs in the lung and is responsible for the fatal outcome of the disease. Thus, a better understanding of the biology of metastasis is needed. In particular, biomarkers to
Mònica Morales   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy